PMA device
Family of DRG IPGs
Abbott Medical · Dorsal Root Ganglion Stimulator For Pain Relief (PMP, Class III) · First FDA decision Jun 26, 2024, newest Jun 26, 2024Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "DRG IPGs"
MAUDE reports
0
Brand "DRG IPGs", since 2015
PubMed studies
0
Mentioning "DRG IPGs"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Family of DRG IPGs
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Family of DRG IPGsPMA supplement
P150004-S071 · Decided Jun 26, 2024 · 89 days after receipt · Normal 180 Day Track
Device type: Dorsal root ganglion stimulator for pain relief (PMP) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "DRG IPGs", any status and sponsor, newest update first.
No registered device study names "DRG IPGs".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DRG IPGs", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMP
20,258 reports: 250 malfunction, 19,968 injury, 32 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DRG IPGs"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PMP.
- Axium Neurostimulator SystemAbbott Medical · PMA 2024
- Proclaim DRG IPG (Model 3664)Abbott Medical · PMA 2023
- Proclaim Dorsal Root Ganglion (DRG) Neurostimulator SystemAbbott Medical · PMA 2026
- Dorsal Root Ganglion (DRG) Neurostimulation SystemAbbott Medical · PMA 2025
- SlimTip Dorsal Root Ganglion (DRG) Trial Lead KitAbbott Medical · PMA 2025
- NextGen DRG Lead Kit and AccessoriesAbbott Medical · PMA 2021
- Proclaim SCS Neurostimulator SystemAbbott Medical · PMA 2021
- PmpAbbott Medical · PMA 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.